News


Since the $87 million HEALing Communities Study was announced just over a year ago, the University of Kentucky and its community and state partners have been working diligently to lay the groundwork to get the project up and running.

A group of University of Kentucky professors and scientists efforts to identify possible direct therapeutic approaches to treat COVID-19 was published in the Perspectives section of the most recent issue of Science, a journal of the American Association for the Advancement of Science (AAAS).

The University of Kentucky’s Sanders-Brown Center on Aging has been a leader in Alzheimer’s Disease related research for many years. The success seen at Sanders-Brown can be directly attributed to the people within the center.
“UK is fantastic at many things, but when it comes to driving the science and the search for cures for diseases like Alzheimer’s, we are second to none,” said Dr. Greg Jicha.

By the UK College of Medicine
Click here for From the Dean's Desk Blog (Dean Robert S. DiPaola, MD)


Comparing pictures from her White Coat ceremony, and one of herself now, Sara Kesh sees a totally different person.
Since starting her medical school journey at the University of Kentucky College of Medicine, Sara has taken it upon herself to not only prioritize her studies, but also to prioritize her personal health, hoping to set an example for the patients she treats and for the future learners that follow in her footsteps.

Researchers in the University of Kentucky College of Nursing’s BREATHE (Bridging Research Efforts and Advocacy Toward Healthy Environments), in conjunction with the Kentucky Geological Survey, the UK College of Public Health, Area Health Education Centers (AHEC), and other community partners in Kentucky were awarded a $2.6 million grant from the National Institute of Environmental Health Sciences to engage and e





Treating surgical patients with pain medicine requires compassionate care and precision, but when it comes to treating young children, there comes an extra layer of attentiveness.
“Before taking children to surgery, we get the question, ‘Is it going to hurt when I wake up?’” Sarah Hall, MD, PhD, assistant professor of anesthesiology at the University of Kentucky College of Medicine, said. “It’s very close to all of our hearts that it’s not an emotionally distressing experience, as we can help it.”

Lung cancer is a complex and devastating disease, especially in the Commonwealth. In fact, Kentuckians are twice as likely as the rest of U.S. citizens to develop squamous cell carcinoma and small-cell lung cancer, both of which are very serious cancers that typically have low survival rates.
Leonard (Leo) Yenwongfai was just 5 years old when he officially solidified his plans to become a doctor. It was after a conversation he had with a physician who was taking care of a family member at the time. That man, also named Leonard, told him, “I want you to be a doctor just like me.”

In response to the COVID-19 pandemic, the University of Kentucky Center for Clinical and Translational Science (CCTS) has created a new biospecimen bank to support research on the novel virus. Logistical support for the biobank is led by the UK Markey Cancer Center.
Connor Appelman, a Maysville, Ky., native, knew from an early age that he wanted to attend medical school just 65 miles down U.S. 68 at the University of Kentucky. As he puts it, he has always bled blue.
“I’m very proud of my home state, and I’ve always wanted to take care of patients in Kentucky,” he said. “That was always the goal growing up, to graduate from the UK College of Medicine. It’s gone by quickly, but it’s been amazing to live out the dream.”

As the worldwide coronavirus COVID-19 pandemic continues to play out, researchers are among those working to find innovative solutions to help flatten the curve.
One such researcher is Jamie Sturgill, assistant professor in the University of Kentucky College of Medicine Department of Internal Medicine. Sturgill's research focuses heavily on lung disease.

Linda J. Van Eldik, director of the Sanders-Brown Center on Aging at the University of Kentucky, co-authored a paper reporting the first human clinical study of a drug candidate that suppresses injury and disease-induced inflammation of the brain.